Comparing visual inspection methods for parenteral products in hospital pharmacy: between reliability, cost, and operator formation considerations.

IF 1.6 4区 医学 Q3 PHARMACOLOGY & PHARMACY
Alexandre Jambon, Marie Forat, Chloé Marchand, Corinne Morel, Camille Merienne, Samira Filali, Fabrice Pirot
{"title":"Comparing visual inspection methods for parenteral products in hospital pharmacy: between reliability, cost, and operator formation considerations.","authors":"Alexandre Jambon, Marie Forat, Chloé Marchand, Corinne Morel, Camille Merienne, Samira Filali, Fabrice Pirot","doi":"10.1136/ejhpharm-2024-004143","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>The COVID-19 pandemic has led to unforeseen and novel manifestations, as illustrated by the management of drug shortages through the development of hospital production of sterile pharmaceutical preparations (P2S). Visual inspection of P2S is a release control whose methods are described in monographs of the European Pharmacopoeia (2.9.20) and the United States Pharmacopeia (1790). However, these non-automated visual methods require training and proficiency testing of personnel. The main objective of this work was to compare the reliability and speed of analysis of two visual methods and an automated method for detecting visible particles by image analysis in P2S. Furthermore, these methods were used to evaluate sources of particulate contamination during pre-production processes (washing, disinfection, depyrogenation) and production (filling, capping).</p><p><strong>Materials and methods: </strong>Three pharmacy technicians examined 41 clear glass vials of type I, 10 and/or 50 mL through manual visual inspection (MVI), semi-automated (SAVI), and automated (AVI) inspection. The vials were distributed as follows: (i) 16 vials of water for injection containing either glass particles (224 µm or 600 µm), stopper fragments, or textile fibres; (ii) five sterile injectable specialties; (iii) 20 vials of water for injection prepared under different pre-production conditions.</p><p><strong>Results and discussion: </strong>MVI and SAVI detected 100% of visible particles compared with 28% for AVI, which showed a deficiency in detecting textile fibres. All three methods correctly analysed P2S that did not contain visible particles. The three methods detected particles in vials maintained under International Organization for Standardization (ISO) 9 pre-production conditions. However, detections by (i) MVI and SAVI, and by (ii) AVI of particles contained in vials maintained under ISO 8 pre-production conditions were deemed satisfactory and unsatisfactory, respectively.</p><p><strong>Conclusion: </strong>The importance of visual inspection of P2S requires rapid, sensitive, and reliable detection methods. In this context, MVI and SAVI have proven to be more effective than AVI for a more competitive financial, training, and implementation investment.</p>","PeriodicalId":12050,"journal":{"name":"European journal of hospital pharmacy : science and practice","volume":" ","pages":""},"PeriodicalIF":1.6000,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European journal of hospital pharmacy : science and practice","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/ejhpharm-2024-004143","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: The COVID-19 pandemic has led to unforeseen and novel manifestations, as illustrated by the management of drug shortages through the development of hospital production of sterile pharmaceutical preparations (P2S). Visual inspection of P2S is a release control whose methods are described in monographs of the European Pharmacopoeia (2.9.20) and the United States Pharmacopeia (1790). However, these non-automated visual methods require training and proficiency testing of personnel. The main objective of this work was to compare the reliability and speed of analysis of two visual methods and an automated method for detecting visible particles by image analysis in P2S. Furthermore, these methods were used to evaluate sources of particulate contamination during pre-production processes (washing, disinfection, depyrogenation) and production (filling, capping).

Materials and methods: Three pharmacy technicians examined 41 clear glass vials of type I, 10 and/or 50 mL through manual visual inspection (MVI), semi-automated (SAVI), and automated (AVI) inspection. The vials were distributed as follows: (i) 16 vials of water for injection containing either glass particles (224 µm or 600 µm), stopper fragments, or textile fibres; (ii) five sterile injectable specialties; (iii) 20 vials of water for injection prepared under different pre-production conditions.

Results and discussion: MVI and SAVI detected 100% of visible particles compared with 28% for AVI, which showed a deficiency in detecting textile fibres. All three methods correctly analysed P2S that did not contain visible particles. The three methods detected particles in vials maintained under International Organization for Standardization (ISO) 9 pre-production conditions. However, detections by (i) MVI and SAVI, and by (ii) AVI of particles contained in vials maintained under ISO 8 pre-production conditions were deemed satisfactory and unsatisfactory, respectively.

Conclusion: The importance of visual inspection of P2S requires rapid, sensitive, and reliable detection methods. In this context, MVI and SAVI have proven to be more effective than AVI for a more competitive financial, training, and implementation investment.

比较医院药房对非肠道注射剂产品的目视检查方法:可靠性、成本和操作员形成之间的考虑因素。
导言:COVID-19 大流行导致了不可预见的新表现形式,通过发展无菌药物制剂 (P2S) 的医院生产来管理药物短缺就是例证。P2S 的目视检查是一种释放控制,其方法在《欧洲药典》(2.9.20)和《美国药典》(1790)的专著中均有描述。然而,这些非自动化的目测方法需要对人员进行培训和能力测试。这项工作的主要目的是比较两种目测方法和一种自动方法的可靠性和分析速度,以便通过图像分析检测 P2S 中的可见微粒。此外,这些方法还用于评估生产前过程(清洗、消毒、去热原)和生产过程(灌装、封盖)中的微粒污染源:三名药房技术人员通过人工目视检查 (MVI)、半自动检查 (SAVI) 和自动检查 (AVI) 检查了 41 个 I 型、10 毫升和/或 50 毫升的透明玻璃小瓶。这些玻璃瓶分布如下(i) 16 瓶含有玻璃微粒(224 微米或 600 微米)、瓶塞碎片或纺织纤维的注射用水;(ii) 5 瓶无菌注射剂;(iii) 20 瓶在不同生产前条件下制备的注射用水:MVI 和 SAVI 检测出 100%的可见微粒,而 AVI 只检测出 28%,在检测纺织纤维方面存在不足。所有三种方法都能正确分析不含可见颗粒的 P2S。这三种方法都能检测出在国际标准化组织 (ISO) 9 预生产条件下保存的样品瓶中的微粒。然而,(i) MVI 和 SAVI 以及(ii) AVI 对在 ISO 8 预生产条件下保存的小瓶中所含颗粒的检测结果分别被认为是令人满意和不令人满意的:结论:P2S 视觉检测的重要性要求采用快速、灵敏和可靠的检测方法。在这种情况下,MVI 和 SAVI 被证明比 AVI 更有效,在财务、培训和实施投资方面更具竞争力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.40
自引率
5.90%
发文量
104
审稿时长
6-12 weeks
期刊介绍: European Journal of Hospital Pharmacy (EJHP) offers a high quality, peer-reviewed platform for the publication of practical and innovative research which aims to strengthen the profile and professional status of hospital pharmacists. EJHP is committed to being the leading journal on all aspects of hospital pharmacy, thereby advancing the science, practice and profession of hospital pharmacy. The journal aims to become a major source for education and inspiration to improve practice and the standard of patient care in hospitals and related institutions worldwide. EJHP is the only official journal of the European Association of Hospital Pharmacists.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信